Sorafenib

Sorafenib__Raf-1 kinase inhibitor BAY 87-2244

Product Name Sorafenib
Description

Raf-1 kinase inhibitor

Purity >99%
CAS No. 284461-73-0
Molecular Formula C21H16ClF3N4O3
Molecular Weight 464.8
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble inDMSO (200mg/ml) or ethanol (3mg/ml)
Source Synthetic
Appearance Off white powder
SMILES CNC(=O)c1cc(ccn1)Oc2ccc(cc2)NC(=O)Nc3ccc(c(c3)C(F)(F)F)Cl
InChI InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)
InChIKey MLDQJTXFUGDVEO-UHFFFAOYSA-N
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.

Cite This Product Sorafenib (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-476)
Alternative Names 4-4-4-chloro-3-(trifluoromethyl)phenylcarbamoylaminophenoxy-N-methylpyridine-2-carboxamide; 4-methylbenzenesulfonic acid
Research Areas Cell Signaling
PubChem ID 216239
Scientific Background Sorafenib display inhibition of multiple kinase targets including, VEGFR, PDGFR, and Raf.
References 1. Juan, L., et al. (2014) Environmental Toxic. Pharm. 38(2): 438–443.